Black Diamond Therapeutics Inc (BDTX)
4.23
-0.18
(-4.08%)
USD |
NASDAQ |
Sep 27, 16:00
4.25
+0.02
(+0.47%)
After-Hours: 18:55
Black Diamond Therapeutics Shareholders Equity (Quarterly): 111.02M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 111.02M |
| March 31, 2024 | 104.31M |
| December 31, 2023 | 116.74M |
| September 30, 2023 | 134.32M |
| June 30, 2023 | 82.20M |
| March 31, 2023 | 98.19M |
| December 31, 2022 | 115.70M |
| September 30, 2022 | 133.23M |
| June 30, 2022 | 152.37M |
| March 31, 2022 | 172.56M |
| December 31, 2021 | 195.90M |
| Date | Value |
|---|---|
| September 30, 2021 | 218.95M |
| June 30, 2021 | 251.02M |
| March 31, 2021 | 280.75M |
| December 31, 2020 | 307.76M |
| September 30, 2020 | 327.34M |
| June 30, 2020 | 343.12M |
| March 31, 2020 | 355.26M |
| December 31, 2019 | -47.16M |
| September 30, 2019 | 76.09M |
| December 31, 2018 | -15.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-47.16M
Minimum
Dec 2019
355.26M
Maximum
Mar 2020
176.48M
Average
143.34M
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 28.21B |
| Ligand Pharmaceuticals Inc | 775.20M |
| Agios Pharmaceuticals Inc | 660.51M |
| ADMA Biologics Inc | 188.27M |
| AnaptysBio Inc | 9.879M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 149.99M |
| Total Liabilities (Quarterly) | 38.96M |